Charles River Labs EVP Joseph LaPlume Sells 428 Shares in May 2026

This Form 4 filing reports two stock sale transactions by Joseph W. LaPlume, Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International, Inc. On May 26, 2026, LaPlume sold 243 shares of common stock at $160.30 per share, reducing his holdings to 27,205 shares. The following day on May 27, 2026, he sold an additional 185 shares at $156.73 per share, bringing his total holdings to 27,020 shares. Both transactions were executed as direct ownership sales. The filing indicates these are routine Form 4 transactions required for corporate insiders to report changes in their ownership positions. The sales represent a total of 428 shares disposed of over two consecutive days.